EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Covalent modification of Keap1 Cys489 by NU6300 activates Nrf2 signaling and suppresses NLRP3 inflammasome-mediated pyroptosis

Xueqin Jiang, Hongyu Zheng, Xinlu Zhang, Minghai Tang, Jing Peng, Xiaoying Cai, Kaiyue Su, Ruijia Zhang, Neng Ye, Lei Lin, Rupei Ma, Caiyun Shen und 2 weitere

Journal of Pharmaceutical Analysis · 2026-03 · 16 (3) · 101458

DOI: 10.1016/j.jpha.2025.101458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-03. Verfasst von Xueqin Jiang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Department of Sichuan Province, West China Hospital, Sichuan University, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear factor erythroid 2-related factor 2 (Nrf2), a master regulator of oxidative stress and inflammasome, plays a critical role in modulating pyroptosis. In this study, we identified NU6300 as a novel small-molecule activator of Nrf2 that restores mitochondrial function, alleviates oxidative stress, and suppresses inflammasome activation and pyroptosis. Mechanistically, NU6300 covalently modified Kelch-like ECH-associated protein 1 (Keap1) at cysteine-489, disrupting the Keap1-Nrf2 interaction, thereby promoting Nrf2 nuclear translocation and transcription of antioxidant genes. Notably, NU6300 inhibits NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activation and gasdermin D (GSDMD)-mediated pyroptosis through redox-dependent mechanisms, representing the first evidence that covalent modification of Keap1 at cysteine-489 by NU6300 bridges Nrf2 activation and inflammasome suppression. In vivo, NU6300 exhibits potent antioxidant and anti-inflammatory protection against acetaminophen (APAP)-induced acute liver injury in mice. Collectively, these findings demonstrate that NU6300 is a novel Nrf2 activator and offers a promising therapeutic strategy for pyroptosis-driven inflammatory diseases.

Schlagwörter

Stichwörter der Autor:innen

Keap1-Nrf2Liver injuryNLRP3 inflammasomeNU6300Pyroptosis

Autor:innen und Institutionen

  • Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • School of Pharmacy, Chengdu Medical College, Chengdu, 610500, China.
  • Scaled Manufacturing Center of Biological Products, Management Office of National Facility for Translational Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Division of Thyroid Surgery, Department of General Surgery and Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chen…

Förderung

  • Science and Technology Department of Sichuan Province
  • West China Hospital, Sichuan University
  • Sichuan University
  • National Natural Science Foundation of China

Zitieren

APA

Jiang, X., Zheng, H., Zhang, X., Tang, M., Peng, J., Cai, X., Su, K., Zhang, R., Ye, N., Lin, L., Ma, R., Shen, C., Wu, W., & Ye, H. (2026). Covalent modification of Keap1 Cys489 by NU6300 activates Nrf2 signaling and suppresses NLRP3 inflammasome-mediated pyroptosis. Journal of Pharmaceutical Analysis, 16(3), 101458. https://doi.org/10.1016/j.jpha.2025.101458

Vancouver

Jiang X, Zheng H, Zhang X, Tang M, Peng J, Cai X, et al. Covalent modification of Keap1 Cys489 by NU6300 activates Nrf2 signaling and suppresses NLRP3 inflammasome-mediated pyroptosis. Journal of Pharmaceutical Analysis. 2026;16(3):101458. doi:10.1016/j.jpha.2025.101458

BibTeX
@article{Jiang2026,
  author = {Jiang, Xueqin and Zheng, Hongyu and Zhang, Xinlu and Tang, Minghai and Peng, Jing and Cai, Xiaoying and Su, Kaiyue and Zhang, Ruijia and Ye, Neng and Lin, Lei and Ma, Rupei and Shen, Caiyun and Wu, Wenshuang and Ye, Haoyu},
  title = {Covalent modification of Keap1 Cys489 by NU6300 activates Nrf2 signaling and suppresses NLRP3 inflammasome-mediated pyroptosis},
  journal = {Journal of Pharmaceutical Analysis},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {101458},
  doi = {10.1016/j.jpha.2025.101458}
}
Kostenlos starten →